Japan Tissue Engineering Co., Ltd. provided earnings guidance for the fiscal year ending March 31, 2023. For the period, the company expected net sales of JPY 2,540 million, operating loss of JPY 389 million, net loss of JPY 388 million and net loss per share of JPY 9.57.
Japan Tissue Engineering Co., Ltd.
Equities
7774
JP3389610001
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
606 JPY | -0.98% | +0.17% | +19.76% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.76% | 159M | |
+9.81% | 126B | |
-5.47% | 11.33B | |
+4.83% | 9.27B | |
+36.31% | 5.5B | |
-24.25% | 4.61B | |
+8.66% | 3.45B | |
-9.65% | 2.81B | |
-10.99% | 2.09B | |
-10.20% | 2.08B |
- Stock Market
- Equities
- 7774 Stock
- News Japan Tissue Engineering Co., Ltd.
- Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023